(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.28%.
Sol Gel Technologies's earnings in 2026 is -$16,337,000.On average, 6 Wall Street analysts forecast SLGL's earnings for 2026 to be -$28,469,058, with the lowest SLGL earnings forecast at -$41,807,003, and the highest SLGL earnings forecast at -$17,016,610. On average, 5 Wall Street analysts forecast SLGL's earnings for 2027 to be -$30,734,338, with the lowest SLGL earnings forecast at -$53,935,205, and the highest SLGL earnings forecast at -$17,016,610.
In 2028, SLGL is forecast to generate -$7,179,880 in earnings, with the lowest earnings forecast at -$11,229,817 and the highest earnings forecast at -$2,750,159.